So your argument is that the company is evaluated by what it DOESNT have? I don’t see it that way. The clearview and implant are pretty big all in their own and Hygieia is no slouch. Regardless of what they haven’t delivered they have at least several verifiable product lines that are potentially pretty big. Of course that’s just my opinion. Anyone can invest in what they see as a good deal